共 38 条
3D origami electrochemiluminescence immunodevice based on porous silver-paper electrode and nanoporous silver double-assisted signal amplification
被引:27
作者:
Li, Weiping
[1
]
Li, Long
[1
]
Li, Shuai
[1
]
Wang, Xiu
[1
]
Li, Meng
[1
]
Wang, Shaowei
[2
]
Yu, Jinghua
[1
]
机构:
[1] Univ Jinan, Sch Chem & Chem Engn, Shandong Univ, Key Lab Chem Sensing & Anal, Jinan 250022, Peoples R China
[2] Univ Jinan, Shandong Prov Key Lab Fluorine Chem & Chem Mat, Jinan 250022, Peoples R China
关键词:
Electrochemiluminescence immunosensor;
Tumor markers;
Microfluidic origami device;
Point-of-care testing;
LAB-ON-PAPER;
ELECTROCHEMICAL IMMUNOSENSOR;
MULTIPLEXED DETECTION;
QUANTUM DOTS;
GOLD;
BIOMARKERS;
GRAPHENE;
PLATFORM;
D O I:
10.1016/j.snb.2013.07.058
中图分类号:
O65 [分析化学];
学科分类号:
070302 ;
081704 ;
摘要:
A highly sensitive electrochemiluminescence (ECL) immunosensor combined with a 3D origami device for detection of carcinoembryonic antigen (CEA) was developed based on novel porous silver nanoparticles modified paper working electrode (Ag-PWE) as sensor platform and CdTe quantum dots functionalized nanoporous silver (QDs/NPS) as signal amplification label. The microfluidic origami device was fabricated by directly screen-printed electrodes on wax-patterned cellulose paper in bulk. The Ag-PWE was fabricated by a seed-mediated growth approach and served as an effective matrix for antibody attachment with good bioactivity, and stability. The ECL nanoprobe (Ab2RD5/NPS) was designed by covalent assembly of signal antibodies (Ab(2)) on QDs/NPS. After a sandwich immunoreaction, the functionalized NPS labels were captured onto the Ag-PWE surface. On the basis of the considerably amplified ECL signal and sandwich-type format, the proposed method successfully fulfilled the highly sensitive detection of CEA with a linear range of 0.5 pg mL(-1) to 20 ng mL(-1) with a detection limit of 0.12 pg mL(-1). This facile origami ECL immunodevice exhibited high sensitivity, specificity and excellent performance in real human serum assay, and could be applied in point-of-care testing of other tumor markers for remote regions and developing countries. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:417 / 424
页数:8
相关论文